文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

糖尿病与糖尿病前期对结核治疗结局的影响:多中心前瞻性队列研究

The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study.
PubMed 文献 · J Infect Dis · 2022-01-01

该研究基于巴西RePORT-Brazil队列(N=643)和SINAN国家报告系统(N=20 989)的2015-2019年数据,评估血糖状态与结核治疗结局的关联。结果显示,糖尿病(而非糖尿病前期)与不良结局和死亡风险升高独立相关,提示需针对合并糖尿病的结核患者改善治疗结局。

要点

  • 糖尿病与结核不良结局风险升高相关(RePORT-Brazil aRR 2.45,SINAN aRR 1.76)。
  • 糖尿病与结核治疗期间死亡风险升高相关(RePORT-Brazil aRR 2.16,SINAN aRR 1.93)。
  • 糖尿病前期未显示与不良结局或死亡风险显著相关。

核心结论

  • 在巴西药物敏感结核患者中,糖尿病与不良治疗结局和死亡风险升高相关。

研究设计与样本

  • 多中心前瞻性队列研究,纳入RePORT-Brazil队列2015-2019年培养确诊药物敏感结核患者N=643,并按基线糖化血红蛋白分层。
  • 利用SINAN国家报告系统2015-2019年数据N=20 989进行验证。

主要发现

  • 单因素分析中,不良结局与吸烟、非法药物使用和HIV感染更频繁相关。
  • 糖尿病与不良结局在RePORT-Brazil(aRR 2.45;P < .001)和SINAN(aRR 1.76;P < .001)中均相关。
  • 糖尿病与结核治疗期间死亡高风险在RePORT-Brazil(aRR 2.16;P = .040)和SINAN(aRR 1.93;P = .001)中均相关。
  • 糖尿病前期与不良结局无显著关联。

关键数值与推荐

  • 不良结核结局定义为治疗失败或方案调整、复发或死亡;良好结局为治愈或完成治疗。
  • 血糖状态根据基线糖化血红蛋白分层。

临床怎么用

  • 对合并糖尿病的结核患者应加强治疗管理以改善结局。
  • 糖尿病前期患者的不良结局风险未见显著升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unclear whether diabetes or prediabetes affects unfavorable treatment outcomes and death in people with tuberculosis (PWTB). METHODS: Culture-confirmed, drug-susceptible PWTB, enrolled in the Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil cohort between 2015 and 2019 (N = 643) were stratified based on glycemic status according to baseline glycated hemoglobin. Unfavorable tuberculosis (TB) outcome was defined as treatment failure or modification, recurrence, or death; favorable outcome was cure or treatment completion. We corroborated the findings using data from PWTB reported to the Brazilian National System of Diseases Notification (SINAN) during 2015-2019 (N = 20 989). Logistic regression models evaluated associations between glycemic status and outcomes. RESULTS: In both cohorts, in univariate analysis, unfavorable outcomes were more frequently associated with smoking, illicit drug use, and human immunodeficiency virus infection. Diabetes, but not prediabetes, was associated with unfavorable outcomes in the RePORT-Brazil (adjusted relative risk [aRR], 2.45; P < .001) and SINAN (aRR, 1.76; P < .001) cohorts. Furthermore, diabetes was associated with high risk of death (during TB treatment) in both RePORT-Brazil (aRR, 2.16; P = .040) and SINAN (aRR, 1.93; P = .001). CONCLUSIONS: Diabetes was associated with an increased risk of unfavorable outcomes and mortality in Brazilian PWTB. Interventions to improve TB treatment outcomes in persons with diabetes are needed.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, et al. The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study. J Infect Dis. 2022. PMID: 34651642. doi:10.1093/infdis/jiab427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。